Accounts Payable

3 Months Ended

Mar. 31, 2013

Accounts Payable Disclosure [Abstract]

Accounts Payable

4. Accounts Payable

As of March 31, 2013, Current Liabilities included accounts payable of $71,875 comprised primarily of approximate amounts owed to the Company’s drug contract manufacturers totaling $10,600, $15,900 to the company providing clinical operations management for Bio-Path’s clinical trial and $45,400 to the Company’s attorneys and auditors for work on the Annual 10K report. As of December 31, 2012, Current Liabilities included accounts payable $57,000 and accounts payable related party of $8,582, which amounts were subsequently paid in 2013.